Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CD8+ T cells cross-restricted by HLA-B*57 and HLA-E*01 recognize HIV Gag with different functional profiles
Kevin J. Maroney, Michael A. Rose, Allisa K. Oman, Abha Chopra, Hua-Shiuan Hsieh, Zerufael Derza, Rachel Waterworth, Mark A. Brockman, Spyros A. Kalams, Anju Bansal, Paul A. Goepfert
Kevin J. Maroney, Michael A. Rose, Allisa K. Oman, Abha Chopra, Hua-Shiuan Hsieh, Zerufael Derza, Rachel Waterworth, Mark A. Brockman, Spyros A. Kalams, Anju Bansal, Paul A. Goepfert
View: Text | PDF
Research Article AIDS/HIV Infectious disease

CD8+ T cells cross-restricted by HLA-B*57 and HLA-E*01 recognize HIV Gag with different functional profiles

  • Text
  • PDF
Abstract

Few HIV-specific epitopes restricted by non-classical HLA-E have been described, and even less is known about the functional profile of responding CD8+ T cells (CD8s). This study evaluates the functional characteristics of CD8s targeting the Gag epitope KF11 (KAFSPEVIPMF) restricted by either HLA-E (E-CD8s) or HLA-B57 (B57-CD8s). CD8s from 8 people with HIV (PWH) were cocultured with KF11 peptide presented by cell lines expressing HLA-B*57:01, HLA-E*01:01, or HLA-E*01:03. CD8 responses were analyzed using single-cell RNA and TCR sequencing. Supernatants were also assessed for soluble protein profiling. HLA-I multimers were developed to identify CD8s restricted by HLA-B57 and/or HLA-E ex vivo. B57-CD8s secreted higher levels of cytotoxic cytokines such as IFN-γ, whereas E-CD8s produced more chemotactic cytokines, including RANTES, CXCL10 (IP-10), and IL-27, findings that were corroborated through single-cell RNA sequencing. TCR clonotypes stimulated by KF11 were cross-restricted by HLA-B*57 and HLA-E*01:03 as demonstrated by in vitro T cell reporter assays and ex vivo multimer screening. Ex vivo CD8s were singly restricted by HLA-B57 and HLA-E, with dual restriction only observed in PWH with lower viral load. These findings demonstrate that certain HIV-specific CD8s in PWH exhibit dual restriction by HLA-B*57 and HLA-E*01:03, leading to functionally distinct immune responses depending on the restricting allele(s).

Authors

Kevin J. Maroney, Michael A. Rose, Allisa K. Oman, Abha Chopra, Hua-Shiuan Hsieh, Zerufael Derza, Rachel Waterworth, Mark A. Brockman, Spyros A. Kalams, Anju Bansal, Paul A. Goepfert

×

Figure 5

Bioinformatically imputed antigen-specific clonotypes are cross-restricted.

Options: View larger image (or click on image) Download as PowerPoint
Bioinformatically imputed antigen-specific clonotypes are cross-restrict...
(A) Distribution of antigen-specific CD8s within full dataset (Figure 4) as identified through VCR-Seek pipeline for cells with paired CDR3 clonotypes found to significantly increase upon stimulation in any metadata combination. (B) DimPlot of antigen-specific CD8s from A. (C) Reclustered antigen-specific subset. Chosen clonotypes identified as being antigen-specific in 10x experiment through described bioinformatics pipeline were cloned into a Jurkat cell line with an NFAT-luciferase reporter. Transformed cells were then cocultured with 41A3.CD4.A02, 41A3.CD4.B57, 41A3.CD4.E01, or 41A3.CD4.E03 cell lines loaded with KF11. (D and E) The fold change (FC) of all tested clonotypes is shown as a line graph, with the B*57:01, E*01:01, or E*01:03 coculture signal FC of the same clonotype indicated by blue, red, or orange dots, respectively, as luciferase FC over coculture with irrelevant KF11-loaded HLA-A*02–expressing cell line (D). The mean FC of all tested clonotypes in the given graphs is shown below the respective condition, and represented as a bar graph for all tested clonotypes split by the control status where the clonotype was found to be statistically antigen-specific through the original bioinformatics pipeline (E). (F–H) Part A was then broken down by control status for the non-controller (F), controller (G), and ART+ NC (H). The top 1–3 FC clonotypes for every grouping are indicated next to the B57 dot of the indicated clonotype (“Gp…”).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts